Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Cediranib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AZ’s comeback drug cediranib stumbles in phase 3 trial
    AZ’s comeback drug cediranib stumbles in phase 3 trial

    13 Mar 2020

    // Phil Taylor PM LIVE

    http://www.pmlive.com/pharma_news/azs_comeback_drug_cediranib_stumbles_in_phase_3_trial_1329024

    Phil Taylor PM LIVE
    13 Mar 2020
    Share Share
    Update on Phase 3 GY004 for Cediranib and LYNPARZA
    Update on Phase 3 GY004 for Cediranib and LYNPARZA

    12 Mar 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200312005215/en

    BUSINESSWIRE
    12 Mar 2020
    Share Share
    Update on Phase III GY004 trial for cediranib added to Lynparza in platinum-
    Update on Phase III GY004 trial for cediranib added to Lynparza in platinum-

    12 Mar 2020

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2020/update-on-phase-iii-gy004-trial-for-cediranib-added-to-lynparza-in-platinum-sensitive-relapsed-ovarian-cancer.html

    PRESS RELEASE
    12 Mar 2020
    Share Share